Delisting riskPopularity #5,351Earnings are out
NCEL · NASDAQ · Biotechnology

NewcelX (NCEL)

Develops stem-cell-derived islet and astrocyte therapies for diabetes and ALS.

$2.81
vs last close−0.23 (−7.43%)